DIVISLABNSEDivi's Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Sat, 3 Jan · 09:01 IST

Divi's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

DIVISLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Divi's Laboratories has submitted a routine compliance certificate to NSE and BSE under SEBI's Regulation 74(5) for the quarter ended December 31, 2025. The certificate, issued by the company's Registrar & Share Transfer Agent KFin Technologies, confirms that all share dematerialization requests received from depository participants during the quarter were properly processed. It also confirms that the corresponding physical share certificates were mutilated and cancelled, and that the names of the depositories have been updated in the company's register of members within the 15-day SEBI-mandated timeline. The underlying securities remain listed on both BSE and NSE.

Likely market impact

This is a standard quarterly regulatory compliance filing with no material impact on the business, financials, or stock price. It is a procedural requirement applicable to all listed companies and does not signal any corporate action or change.